Effect of coenzyme Q10 evaluated by 1990 and 2010 ACR Diagnostic Criteria for Fibromyalgia and SCL-90-R: Four case reports and literature review

Nutrition

Volumn 29, Issue 11-12, 2013, Pages 1422-1425

  Alcocer Gómez, Elísabet ^a   Cano García, Francisco Javier ^b   Cordero, Mario D ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

ACR criteria; Coenzyme Q10; Fibromyalgia; Scl 90R

Indexed keywords

UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

ADULT; AGED; AMERICAN COLLEGE OF RHEUMATOLOGY DIAGNOSTIC CRITERIA; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM CHECKLIST 90; SYMPTOM SEVERITY SCALE; TRIGGER POINT; VISUAL ANALOG SCALE; WIDESPREAD PAIN INDEX; ACR CRITERIA; ATAXIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MIDDLE AGED; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; QUESTIONNAIRE; REVIEW;

ACR CRITERIA; COENZYME Q10; FIBROMYALGIA; SCL-90R;

ADULT; AGED; ATAXIA; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; MITOCHONDRIAL DISEASES; MUSCLE WEAKNESS; QUESTIONNAIRES; UBIQUINONE;

EID: 84884923685     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.05.005     Document Type: Article

References (36)

1. Battino M., Fato R., Parenti-Castelli G., Lenaz G. Coenzyme Q can control the efficiency of oxidative phosphorylation. Int J Tissue React 1990, 12:137-144.
2. Haas R.H. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease. Mitochondrion 2007, 7:S136-S145.
3. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
4. Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., Katz R.S., Mease P., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
5. Cordero M.D., Moreno-Fernández A.M., deMiguel M., Bonal P., Campa F., Jiménez-Jiménez L.M., et al. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 2009, 42:732-735.
6. Lister R.E. An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J Int Med Res 2002, 30:195-199.
7. Cordero M.D., Alcocer-Gómez E., de Miguel M., Cano-García F.J., Luque C.M., Fernández-Riejo P., et al. Coenzyme Q10: A novel therapeutic approach for Fibromyalgia? Case series with 5 patients. Mitochondrion 2011, 11:623-625.
8. Cordero M.D., Cotán D., del-Pozo-Martín Y., Carrión A.M., de Miguel M., Bullón P., et al. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 2012, 28:1200-1203.
9. Cordero M.D., Díaz-Parrado E., Carrión A.M., Alfonsi S., Sánchez-Alcazar J.A., Bullón P., Battino M., de Miguel M. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?. Antioxid Redox Signal 2013, 18:800-807.
10. Littarru G.P., Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010, 26:250-254.
11. Haas R.H., Parikh S., Falk M.J., Saneto R.P., Wolf N.I., Darin N., et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008, 94:16-37.
12. Rodriguez-Hernandez A., Cordero M.D., Salviati L., Artuch R., Pineda M., Briones P., et al. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 2009, 5:19-32.
13. Cotán D., Cordero M.D., Garrido-Maraver J., Oropesa-Ávila M., Rodríguez-Hernández A., Gómez Izquierdo L., et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J 2011, 25:2669-2687.
14. Ogasahara S., Nishikawa Y., Yorifuji S., Soga F., Nakamura Y., Takahashi M., et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986, 36:45-53.
15. Lamperti C., Naini A.B., Lucchini V., Prelle A., Bresolin N., Moggio M., et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol 2005, 62:1709-1712.
16. Laaksonen R., Jokelainen K., Sahi T., Tikkanen M.J., Himberg J.J. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther 1995, 57:62-66.
17. Paiva H., Thelen K.M., Van Coster R., Smet J., De Paepe B., Mattila K.M., et al. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 2005, 78:60-68.
18. Young J.M., Florkowski C.M., Molyneux S.L., McEwan R.G., Frampton C.M., George P.M., et al. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol 2007, 100:1400-1403.
19. Caso G., Kelly P., McNurlan M.A., Lawson W.E. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007, 99:1409-1412.
20. Cooper J.M., Schapira A.H. Friedreich's ataxia: coenzyme Q10 and vitamin Etherapy. Mitochondrion 2007, (7 Suppl):S127-S135.
21. Cooper J.M., Korlipara L.V., Hart P.E., Bradley J.L., Schapira A.H. Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol 2008, 15:1371-1379.
22. Henchcliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008, 4:600-609.
23. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., et al. Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002, 59:1541-1550.
24. Stamelou M., Reuss A., Pilatus U., Magerkurth J., Niklowitz P., Eggert K.M., et al. Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 2008, 23:942-949.
25. Sándor P.S., Di Clemente L., Coppola G., Saenger U., Fumal A., Magis D., et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005, 64:713-715.
26. Hershey A.D., Powers S.W., Vockell A.L., Lecates S.L., Ellinor P.L., Segers A., et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007, 47:73-80.
27. Evans R.W., de Tommaso M. Migraine and fibromyalgia. Headache 2011, 51:295-299.
28. Gormsen L., Rosenberg R., Bach F.W., Jensen T.S. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 2010, 14:127.e1-127.e8.
29. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 2009, 30:462-469.
30. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett 2009, 30:470-476.
31. Reidenberg M.M. Statins, lack of energy and ubiquinone. Br J Clin Pharmacol 2005, 59:606-607.
32. Mizuno K., Tanaka M., Nozaki S., Mizuma H., Ataka S., Tahara T., et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 2008, 24:293-299.
33. Lenaz G., Fato R., Formiggini G., Genova M.L. The role of Coenzyme Q in mitochondrial electron transport. Mitochondrion 2007, 7:S8-33.
34. Cordero M.D., Alcocer-Gómez E., Cano-García F.J., De Miguel M., Carrión A.M., Navas P., et al. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 2011, 6:e26915.
35. Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM, etal. Can Coenzyme Q10 improve clinical and molecular parameters in fibromyalgia? Antioxid Redox Signal; 2013 http://dx.doi.org/10.1089/ars.2013.5260.
36. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13:251-262.